Although 2.46 million new instances of STIs were reported, the last year saw a significant drop in cases of gonorrhea and primary and secondary syphilis — primarily driven by the LGBTQ+ community.
Emrosi approved by FDA on November 4 for the treatment of inflammatory lesions of rosacea in adults Cosibelimab PDUFA goal date of December 28 for potential approval to treat metastatic or locally adv ...